Relação entre marcadores hematológicos, endócrinos e imunológicos e a sarcopenia em idosos

Autores

  • Ana Paula Pillatt Universidade Regional do Noroeste do Estado do Rio Grande do Sul
  • Ligia Beatriz Bento Franz Universidade Regional do Noroeste do Estado do Rio Grande do Sul
  • Evelise Moraes Berlezi Universidade Regional do Noroeste do Estado do Rio Grande do Sul
  • Rodolfo Herberto Schneider Pontifícia Universidade Católica do Rio Grande do Sul

DOI:

https://doi.org/10.11606/issn.2317-0190.v29i2a181686

Palavras-chave:

Sarcopenia, Força Muscular, Velocidade de Marcha, Biomarcadores, Idoso

Resumo

Objetivo: Relacionar os marcadores hematológicos, endócrinos e imunológicos com os critérios de classificação da sarcopenia em idosos residentes na comunidade. Métodos: Estudo transversal, vinculado à pesquisa institucional “Atenção Integral à Saúde do Idoso”. A população foi composta por indivíduos com idade igual ou superior a 60 anos, ambos os sexos, usuários da atenção primária à saúde. O protocolo de pesquisa contemplou entrevista, avaliação da sarcopenia e exames laboratoriais para avaliação do hemograma, da 25-hidroxivitamina D, paratormônio, fator de crescimento semelhante à insulina-1, interleucina-6 e proteína C reativa. Para análise estatística utilizou-se Teste de Mann-Whitney, Teste de qui-quadrado de Pearson, Exato de Fisher e Odds Ratio. Resultados: Verificou-se relação de interleucina-6 (p= 0,004), eritrócitos (p= 0,038), hemoglobina (p<0,001) e hematócrito (p= 0,002) com sarcopenia. Também observou-se que os idosos com força muscular alterada apresentaram valores mais baixos de hematócrito (p= 0,037) e mais altos de interleucina-6 (p= 0,002); e com desempenho físico alterado apresentaram valores mais baixos de leucócitos (p=0,024), hemoglobina (p<0,001), hematócrito (p= 0,007) e 25-hidroxivitamina D (p= 0,034) e mais altos de paratormônio (p= 0,018) e interleucina-6 (p= 0,002). Conclusão: Sugere-se a avaliação e acompanhamento dos níveis de interleucina-6, paratormônio, 25-hidroxivitamina D e da série vermelha do hemograma durante a prática assistencial.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2018;7(1):2-9. Doi: https://doi.org/10.14283/jfa.2017.30

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. Doi: https://doi.org/10.1093/ageing/afy169

Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y. Sarcopenia. Joint Bone Spine. 2019;86(3):309-314. Doi: https://doi.org/10.1016/j.jbspin.2018.08.001

Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-59. Doi: https://doi.org/10.1093/ageing/afu115

Diz JB, Leopoldino AA, Moreira BS, Henschke N, Dias RC, Pereira LS, et al. Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis. Geriatr Gerontol Int. 2017;17(1):5-16. Doi: https://doi.org/10.1111/ggi.12720

Morley JE, Anker SD, Von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):253-9. Doi: https://doi.org/10.1007/s13539-014-0161y

Wleklik M, Uchmanowicz I, Jankowska EA, Vitale C, Lisiak M, Drozd M, et al. Multidimensional Approach to Frailty. Front Psychol. 2020;11:564. Doi: https://doi.org/10.3389/fpsyg.2020.00564

Mendes GS, Teixeira THMM, Souza VC, Neiva TS, Pereira KP, Landim MFT, et al. Sarcopenia in sedentary elderly and relation with functionality and inflammatory markers (IL-6 and IL-10). Geriatr Gerontol Aging. 2016;10:23-8.

Berlezi EM, Gross CB, Pimentel JJ, Pagno AR, Fortes CK, Pillatt AP. Estudo do fenótipo de fragilidade em idosos residentes na comunidade. Cien Saude Colet. 2019;24(11):4201-10. Doi: https://doi.org/10.1590/1413-812320182411.31072017

Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and Ageing. 2011;40(4): 423-9. Doi: https://doi.org/10.1093/ageing/afr051

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. Doi: https://doi.org/10.1371/journal.pone.0113637

Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2015;34(4):667-73. Doi: https://doi.org/10.1016/j.clnu.2014.07.010

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58. Doi: https://doi.org/10.1093/gerona/glu010

Maggio M, Ceda GP, Ticinesi A, De Vita F, Gelmini G, Costantino C, et al. Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals. PLoS One. 2016;11(4):e0153583. Doi: https://doi.org/10.1371/journal.pone.0153583

Williamson MA, Snyder L. Wallach: Interpretação de exames laboratoriais. 10 ed. Rio de Janeiro: Guanabara Koogan; 2017.

Pagana KD. Guia de exames laboratoriais e de imagem para a enfermagem. 11 ed. Rio de Janeiro: Elsevier; 2015.

Bós ÂJG. EpiInfo® sem mistérios: um manual prático [recurso eletrônico]. Porto Alegre: EDIPUCRS; 2012.

Silva JC, Moraes ZV, Silva C, Mazon SB, Guariento ME, Neri AL, et al. Understanding red blood cell parameters in the context of the frailty phenotype: interpretations of the FIBRA (Frailty in Brazilian Seniors) study. Arch Gerontol Geriatr. 2014; 59 (3): 636-641. Doi: https://doi.org/10.1016/j.archger.2014.07.014

Hirani V, Naganathan V, Blyth F, Le Couteur DG, Seibel MJ, Waite LM, et al. Low hemoglobin concentrations are associated with sarcopenia, physical performance, and disability in older australian men in cross-sectional and longitudinal analysis: The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2016;71(12):1667-75. Doi: https://doi.org/10.1093/gerona/glw055

Röhrig G, Gütgemann I, Kolb G, Leischker A. Anemia in the aged is not ageing related: position paper on anemia in the aged by the "working group anemia" of the German Geriatric Society (DGG). Eur Geriatr Med. 2018;9(3):3957. Doi: https://doi.org/10.1007/s41999-018-0048-0

Machado IE, Malta DC, Bacal NS, Rosenfeld LGM. Prevalência de anemia em adultos e idosos brasileiros. Rev Bras Epidemiol. 2019;22(2):E190008. Doi: https://doi.org/10.1590/1980-549720190008.supl.2

Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood. 2018;131(5):505-14. Doi: https://doi.org/10.1182/blood-2017-07-746446

Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α. Eur J Med Res. 2017;22(1):25. Doi: https://doi.org/10.1186/s40001-017-0266-9

Rong YD, Bian AL, Hu HY, Ma Y, Zhou XZ. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18(1):308. Doi: https://doi.org/10.1186/s12877-018-1007-9

Mikó A, Pótó L, Mátrai P, Hegyi P, Füredi N, Garami A, et al. Gender difference in the effects of interleukin-6 on grip strength - a systematic review and meta-analysis. BMC Geriatr. 2018;18(1):107. Doi: https://doi.org/10.1186/s12877-018-0798-z

Ma L, Sha G, Zhang Y, Li Y. Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults. Clin Interv Aging. 2018;13: 2013-20. Doi: https://doi.org/10.2147/CIA.S180934

Kwak JY, Hwang H, Kim SK, Choi JY, Lee SM, Bang H, et al. Prediction of sarcopenia using a combination of multiple serum biomarkers. Sci Rep. 2018;8(1):8574. Doi: https://doi.org/10.1038/s41598-018-26617-9

De Vita F, Lauretani F, Bauer J, Bautmans I, Shardell M, Cherubini A, et al. Relationship between vitamin D and inflammatory markers in older individuals. Age (Dordr). 2014; 36 (4): 9694. Doi: https://doi.org/10.1007/s11357-014-9694-4

Liberman K, Njemini R, Luiking Y, Forti LN, Verlaan S, Bauer JM, et al. Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study. Aging Clin Exp Res. 2019;31(6):845-54. Doi: https://doi.org/10.1007/s40520-019-01208-4

Hirani V, Cumming RG, Naganathan V, Blyth F, Le Couteur DG, Hsu B, et al. Longitudinal associations between vitamin D metabolites and sarcopenia in older australian men: The Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci. 2017; 73 (1): 131-138. Doi: https://doi.org/10.1093/gerona/glx086

Chang WT, Wu CH, Hsu LW, Chen PW, Yu JR, Chang CS, et al. Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Sci Rep. 2017;7: 40996. Doi: https://doi.org/10.1038/srep40996

Montero-Odasso M, Sakurai R, Muir-Hunter S, Islam A, Doherty T, Duque G, et al. Serum parathyroid hormone but not vitamin D is associated with impaired gait in community-dwelling older adults. J Am Geriatr Soc. 2016; 64(12):2606-8. Doi: https://doi.org/10.1111/jgs.14501

Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Murthy L, Grill V, et al. High parathyroid hormone levels are associated with osteosarcopenia in older individuals with a history of falling. Maturitas. 2018;113:21-5. Doi: https://doi.org/10.1016/j.maturitas.2018.04.006

Kotlarczyk MP, Perera S, Ferchak MA, Nace DA, Resnick NM, Greenspan SL. Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation. Osteoporos Int. 2017;28(4):1347-53. Doi: https://doi.org/10.1007/s00198-016-3877-z

Saedi AA, Feehan J, Phu S, Duque G. Current and emerging biomarkers of frailty in the elderly. Clin Interv Aging. 2019; 14:389-98. Doi: https://doi.org/10.2147/CIA.S168687

Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies; 2011.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911-30. Doi: https://doi.org/10.1210/jc.2011-0385

American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc. 2014;62(1): 147-52. Doi: https://doi.org/10.1111/jgs.12631

Downloads

Publicado

2022-06-28

Edição

Seção

Artigo Original

Dados de financiamento

Como Citar

1.
Pillatt AP, Franz LBB, Berlezi EM, Schneider RH. Relação entre marcadores hematológicos, endócrinos e imunológicos e a sarcopenia em idosos. Acta Fisiátr. [Internet]. 28º de junho de 2022 [citado 21º de novembro de 2024];29(2):67-74. Disponível em: https://periodicos.usp.br/actafisiatrica/article/view/181686